p18SRP Inhibitors
p18SRP inhibitors encompass a diverse range of chemical compounds that interfere with various signaling pathways, thus indirectly influencing the functionality of p18SRP. One such inhibitor acts by targeting protein kinases, leading to the inhibition of phosphorylation events that are crucial for the activation of proteins within specific signaling pathways; p18SRP, being a protein potentially regulated by such phosphorylation-dependent processes, would thus experience an inhibition of its functional activity. Another inhibitor exerts its effects by specifically antagonizing the PI3K/Akt pathway, which is known to play a pivotal role in the regulation of numerous proteins, p18SRP included; the downregulation of this pathway results in a decreased functional activity of p18SRP. Certain inhibitors work by suppressing key signaling nodes, such as MEK1/2 and ERK, which are integral to the MAPK/ERK pathway, a pathway that may be involved in the regulation of p18SRP and its associated cellular activities.
Moreover, the inhibition of mTOR by specific compounds can lead to the suppression of downstream signaling required for the functional activity of p18SRP, as mTOR is a central controller of protein synthesis and cell growth. Other inhibitors target the proteasome, leading to the accumulation of misfolded proteins, which can disrupt the cellular environment and impede the stability and activity of proteins like p18SRP. Additionally, the interference with p38 MAPK signaling by certain inhibitors would modulate the cellular response to stress signals, which could affect the regulation of p18SRP activity. Similarly, the inhibition of JNK signaling can have indirect consequences on p18SRP by altering the signaling pathways that regulate its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent kinase inhibitor that by blocking the phosphorylation events can indirectly inhibit the function of p18SRP by preventing its activation through phosphorylation-dependent processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A specific inhibitor of PI3K, leading to the downregulation of PI3K/Akt pathway components, which can indirectly inhibit p18SRP by diminishing the signaling events that promote its functional activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A selective inhibitor of MEK1/2, which inhibits ERK phosphorylation, thereby impacting downstream proteins like p18SRP which may be regulated by the MAPK/ERK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor which can suppress downstream signaling required for the functional activity of p18SRP, as mTOR is a key regulator of protein synthesis and cell growth. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor which can lead to the accumulation of misfolded proteins, potentially disrupting the cellular environment and indirectly inhibiting p18SRP by affecting its stability. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor which can interfere with signaling pathways that potentially regulate p18SRP activity by modulating responses to cellular stress signals. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that prevents activation of the MAPK/ERK pathway, potentially affecting downstream proteins including p18SRP by altering signaling required for their activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which could indirectly inhibit p18SRP by disrupting the JNK signaling pathway potentially involved in the regulation of its activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A potent PI3K inhibitor, leading to the inhibition of AKT signaling and potentially affecting downstream proteins such as p18SRP that may rely on this pathway for proper functioning. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor which could indirectly affect p18SRP by altering the acetylation status of histones and thus, potentially influencing the expression of genes that regulate its activity. | ||||||